{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:44:42Z","timestamp":1766123082203,"version":"3.48.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020964","name":"Japan Science and Technology Agency Fusion Oriented REsearch for disruptive Science and Technology","doi-asserted-by":"publisher","award":["JPMJFR205J"],"award-info":[{"award-number":["JPMJFR205J"]}],"id":[{"id":"10.13039\/501100020964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21nf0101635"],"award-info":[{"award-number":["JP21nf0101635"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.128020","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T12:46:33Z","timestamp":1764420393000},"page":"128020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence of HPV vaccine\u2013associated symptoms in unvaccinated Japanese adolescents: A descriptive study from the VENUS study database"],"prefix":"10.1016","volume":"70","author":[{"given":"Yurika","family":"Kawazoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Katsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitsugu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntaro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futoshi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhisa","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.128020_bb0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128020_bb0010","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1038\/s41598-018-23947-6","article-title":"Dynamic changes in Japan's prevalence of abnormal findings in cervical cervical cytology depending on birth year","volume":"8","author":"Ueda","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128020_bb0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/infdis\/jiy516","article-title":"Bivalent human papillomavirus vaccine effectiveness in a Japanese population: high vaccine-type-specific effectiveness and evidence of cross-protection","volume":"219","author":"Kudo","year":"2019","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128020_bb0020","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1111\/cas.14212","article-title":"Reduction in HPV16\/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program","volume":"110","author":"Matsumoto","year":"2019","journal-title":"Cancer Sci"},{"issue":"14","key":"10.1016\/j.vaccine.2025.128020_bb0025","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128020_bb0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/cas.14682","article-title":"Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: a nationwide case-control study","volume":"112","author":"Ikeda","year":"2021","journal-title":"Cancer Sci"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128020_bb0035","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1111\/cas.15060","article-title":"A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan","volume":"112","author":"Yagi","year":"2021","journal-title":"Cancer Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128020_bb0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/vaccines10020256","article-title":"Long-term effects of human papillomavirus vaccination in clinical trials and real-world data: a systematic review","volume":"10","author":"Kurosawa","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128020_bb0045","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2023.4800","article-title":"Population-level health effects of involuntary displacement of people experiencing unsheltered homelessness who inject drugs in US cities","volume":"329","author":"Barocas","year":"2023","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.vaccine.2025.128020_bb0050","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128020_bb0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","article-title":"Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States","volume":"36","author":"Chaturvedi","year":"2018","journal-title":"J Clin Oncol"},{"issue":"41","key":"10.1016\/j.vaccine.2025.128020_bb0060","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128020_bb0065","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s12889-020-08753-y","article-title":"The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis","volume":"20","author":"Luk\u00e1cs","year":"2020","journal-title":"BMC Public Health"},{"issue":"9987","key":"10.1016\/j.vaccine.2025.128020_bb0085","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/S0140-6736(15)61152-7","article-title":"HPV vaccination crisis in Japan","volume":"385","author":"Hanley","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128020_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14760584.2019.1584040","article-title":"HPV vaccination in Japan: what is happening in Japan?","volume":"18","author":"Ikeda","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128020_bb0095","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/S2468-2667(20)30010-4","article-title":"Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study","volume":"5","author":"Simms","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2025.128020_bb0100","unstructured":"Japan Society of Obstetrics and Gynecology, \u201cToward a Correct Understanding of Cervical Cancer and the HPV Vaccine.\u201d [Online]. Available: https:\/\/www.jsog.or.jp\/citizen\/5765\/. [Accessed: 10-Apr-2025]."},{"issue":"43","key":"10.1016\/j.vaccine.2025.128020_bb0105","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Electronic address: sageexecsec@who.int, \u201cHuman papillomavirus vaccines: WHO position paper, May 2017-Recommendations,\u201d","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128020_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.22513","article-title":"Human papillomavirus vaccination by birth fiscal year in Japan","volume":"7","author":"Yagi","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128020_bb0115","first-page":"179","article-title":"Vaccine hesitancy(\u30ef\u30af\u30c1\u30f3\u8e8a\u8e87):\u30ef\u30af\u30c1\u30f3\u63a5\u7a2e\u610f\u601d\u306b\u4e0e\u3048\u308b\u8af8\u8981\u56e0\u3068\u8077\u5834 (vaccine hesitancy(wakuchin ch\u016bcho): Wakuchin sesshuishi ni ataeru syoyouin to syokuba)[vaccine hesitancy: factors influencing intention to vaccinate and the workplace]","volume":"34","author":"Mori","year":"2022","journal-title":"Occup Health Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128020_bb0120","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4387","article-title":"Safety profile of the 9-valent HPV vaccine: a combined analysis of 7 phase III clinical trials","volume":"138","author":"Moreira","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128020_bb0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jadohealth.2017.08.004","article-title":"Reports of postural orthostatic tachycardia syndrome after human papillomavirus vaccination in the vaccine adverse event reporting system","volume":"61","author":"Arana","year":"2017","journal-title":"J Adolesc Health"},{"issue":"13","key":"10.1016\/j.vaccine.2025.128020_bb0130","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.vaccine.2018.02.034","article-title":"Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the vaccine adverse event reporting system (VAERS), 2009-2015","volume":"36","author":"Arana","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128020_bb0135","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1808","article-title":"Near real-time surveillance to assess the safety of the 9-valent human papillomavirus vaccine","volume":"144","author":"Donahue","year":"2019","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128020_bb0140","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1791","article-title":"Safety of the 9-valent human papillomavirus vaccine","volume":"144","author":"Shimabukuro","year":"2019","journal-title":"Pediatrics"},{"year":"2025","author":"Horibe","key":"10.1016\/j.vaccine.2025.128020_bb0145"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128020_bb0160","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.vaccine.2024.01.025","article-title":"What would have happened anyway? Population data source considerations when estimating background incident rates of adverse events following immunisation to inform vaccine safety","volume":"42","author":"Clothier","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128020_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2188\/jea.JE20210277","article-title":"A nationwide epidemiological survey of adolescent patients with diverse symptoms similar to those following human papillomavirus vaccination: background prevalence and incidence for considering vaccine safety in Japan","volume":"32","author":"Fukushima","year":"2022","journal-title":"J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.128020_bb0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pvr.2018.05.002","article-title":"Differential misclassification between self-reported status and official HPV vaccination records in Japan: implications for evaluating vaccine safety and effectiveness","volume":"6","author":"Yamaguchi","year":"2018","journal-title":"Papillomavirus Res"},{"issue":"42","key":"10.1016\/j.vaccine.2025.128020_bb0185","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The vaccine safety datalink: successes and challenges monitoring vaccine safety","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2025.128020_bb0190","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1016\/j.vaccine.2022.08.069","article-title":"Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: the vaccine effectiveness, networking, and universal safety (VENUS) study","volume":"40","author":"Ishiguro","year":"2022","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128020_bb0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2188\/jea.JE20210513","article-title":"The Longevity Improvement & Fair Evidence (LIFE) study: overview of the study design and baseline participant profile","volume":"33","author":"Fukuda","year":"2023","journal-title":"J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.128020_bb0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pvr.2018.02.002","article-title":"No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study","volume":"5","author":"Suzuki","year":"2018","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.vaccine.2025.128020_bb0205","unstructured":"\u201cPortal Site of Official Statistics of Japan,\u201d Portal Site of Official Statistics of Japan. [Online]. Available: https:\/\/www.e-stat.go.jp\/en. [Accessed: 26-June-2025]."},{"issue":"10","key":"10.1016\/j.vaccine.2025.128020_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:41:45Z","timestamp":1766122905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S0264410X25013180"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of HPV vaccine\u2013associated symptoms in unvaccinated Japanese adolescents: A descriptive study from the VENUS study database","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128020"}}